Medical technology company, IRIDEX Corporation, is making waves in the field of ophthalmology with its range of laser systems, delivery devices, and consumable instrumentation. Offering an array of options including the Cyclo G6 laser system for glaucoma treatment, the IQ 532 and IQ 577 for the treatment of retinal disorders, and the OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems for treating conditions like proliferative diabetic retinopathy and retinal tears, the company is providing solutions to a range of sight-threatening diseases. Additionally, IRIDEX offers delivery devices such as the TxCell scanning laser delivery system, slit lamp adapter, and laser indirect ophthalmoscope. The company also provides the MicroPulse P3 Probe for performing MicroPulse transscleral laser therapy, the G-Probe for treating uncontrolled glaucoma, and the EndoProbe for vitrectomy procedures. Along with serving ophthalmologists, the company markets its products through direct and independent sales forces within the United States and independent distributors globally. IRIDEX Corporation's headquarters are located in Mountain View, California, and the company was incorporated in 1989, previously known as IRIS Medical Instruments, Inc. before changing its name to IRIDEX Corporation in November of 1995.